Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

SELUTION4BTK Trial

NCT: NCT05055297 · RECRUITING

NCT IDNCT05055297
StatusRECRUITING
Start Date2022-05-19
Completion2032-07-30

Brief Summary

This study aims to demonstrate superior efficacy and equivalent safety of the SELUTION SLR™ DEB 014 compared to plain (uncoated) balloon angioplasty in the treatment of peripheral arterial disease (PAD) in the BTK arteries in CLTI patients.

Frequently Asked Questions

What is SELUTION4BTK Trial?

SELUTION4BTK Trial is a clinical trial registered under NCT05055297. Current status: RECRUITING.

What is the status of NCT05055297?

The current status of NCT05055297 (SELUTION4BTK Trial) is: RECRUITING.

When did SELUTION4BTK Trial start?

SELUTION4BTK Trial started on 2022-05-19.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑